These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30726855)

  • 1. Utility of Cardiac Biomarkers in the Setting of Kidney Disease.
    Savoj J; Becerra B; Kim JK; Fusaro M; Gallieni M; Lombardo D; Lau WL
    Nephron; 2019; 141(4):227-235. PubMed ID: 30726855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease.
    deFilippi CR; Herzog CA
    Clin Chem; 2017 Jan; 63(1):59-65. PubMed ID: 27811207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac markers and cardiovascular disease in chronic kidney disease.
    Chen YJ; Chen CC; Er TK
    Adv Clin Chem; 2023; 115():63-80. PubMed ID: 37673522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction.
    Parikh RH; Seliger SL; deFilippi CR
    Clin Biochem; 2015 Mar; 48(4-5):247-53. PubMed ID: 25617663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac troponins and chronic kidney disease.
    Kanderian AS; Francis GS
    Kidney Int; 2006 Apr; 69(7):1112-4. PubMed ID: 16531987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury.
    Wang S; Qin L; Wu T; Deng B; Sun Y; Hu D; Mohan C; Zhou XJ; Peng A
    Med Sci Monit; 2014 Oct; 20():2043-53. PubMed ID: 25344353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in kidney and heart disease.
    Maisel AS; Katz N; Hillege HL; Shaw A; Zanco P; Bellomo R; Anand I; Anker SD; Aspromonte N; Bagshaw SM; Berl T; Bobek I; Cruz DN; Daliento L; Davenport A; Haapio M; House AA; Mankad S; McCullough P; Mebazaa A; Palazzuoli A; Ponikowski P; Ronco F; Sheinfeld G; Soni S; Vescovo G; Zamperetti N; Ronco C;
    Nephrol Dial Transplant; 2011 Jan; 26(1):62-74. PubMed ID: 20978142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Novel Inflammatory Biomarkers in Renal Disease.
    Marinaki S; Skalioti C; Siasos G; Papavassiliou AG; Tousoulis D; Boletis JN
    Curr Med Chem; 2015; 22(23):2786-800. PubMed ID: 25876748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort.
    Levin A; Rigatto C; Barrett B; Madore F; Muirhead N; Holmes D; Clase CM; Tang M; Djurdjev O;
    Nephrol Dial Transplant; 2014 May; 29(5):1037-47. PubMed ID: 24371297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.
    Zakeri R; Burnett JC; Sangaralingham SJ
    Clin Chim Acta; 2015 Mar; 443():108-13. PubMed ID: 25512164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers determining cardiovascular risk in patients with kidney disease.
    Siasos G; Tousoulis D; Michalea S; Oikonomou E; Kolia C; Kioufis S; Synetos A; Vlasis K; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2555-71. PubMed ID: 22489717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--.
    Iwanaga Y; Miyazaki S
    Circ J; 2010 Jul; 74(7):1274-82. PubMed ID: 20558890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.
    Fujii H; Nishijima F; Goto S; Sugano M; Yamato H; Kitazawa R; Kitazawa S; Fukagawa M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2089-95. PubMed ID: 19188341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Biomarkers of Heart Failure.
    Savic-Radojevic A; Pljesa-Ercegovac M; Matic M; Simic D; Radovanovic S; Simic T
    Adv Clin Chem; 2017; 79():93-152. PubMed ID: 28212715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in acute heart failure.
    Mallick A; Januzzi JL
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):514-25. PubMed ID: 25911167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.